Poor effect of osimertinib on EGFR exon 20 insertion-positive lung adenocarcinoma: A case report

INTRODUCTION: The clinical efficacy of osimertinib for patients with lung adenocarcinoma harboring epidermal growth factor receptor (EGFR) exon 20 insertion mutations is unclear. Few case reports exist on the successful treatment of such tumors with osimertinib. We report a case wherein osimertinib...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Inagaki, Yuji, Tamiya, Akihiro, Matsuda, Yoshinobu, Azuma, Kouji, Adachi, Yuichi, Enomoto, Takatoshi, Kouno, Shunichi, Taniguchi, Yoshihiko, Saijo, Nobuhiko, Okishio, Kyoichi, Atagi, Shinji
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2020
Assuntos:
5700
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7572000/
https://ncbi.nlm.nih.gov/pubmed/33080698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000022628
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados